Warning letter
Morningstar Minerals LLC: warning letter of Jun 1, 2020
FDA warning letter 599745 · Division of Human and Animal Food Operations West IV
Key facts
| Reference number | 599745 |
|---|---|
| Company | Morningstar Minerals LLC |
| Subject | Unapproved New Drugs/Misbranded |
| Issue date | Jun 1, 2020 |
| Posted date | Jun 16, 2020 |
| Issuing office | Division of Human and Animal Food Operations West IV |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.4, 101.5, 101.36, 111, 111.95, 111.210, 111.255, 101.36(b)(3)(iv), 101.36(e)(1), 101.36(e)(7), 101.93(b), 101.2(d) and 32 more |
| Inspection city | Farmington |
| Inspection ZIP | 87401 |
| Inspection start date | Nov 19, 2019 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: